Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Precision Medicine Approaches to Guide Anti-platelet Selection Following Percutaneous Coronary Intervention (PCI)

NCT04090281 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT04090281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04090281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Precision Medicine Approaches to Guide Anti-platelet Selection Following Percutaneous Coronary Intervention (PCI)
Lead sponsor
University of Southern California
Phase
Phase 4
Overall status
Unknown status
Start date
March 13, 2020
Completion date
November 30, 2023
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs), nstemi - non-st segment elevation mi, stemi - st elevation myocardial infarction (mi), unstable angina (ua)